Ontario is investing Can$4.9 million (US$3.92 million) in a Can$32 million expansion programme that will double the research and development capacity of US-based pain specialist Purdue Pharma in the Canadian province.

The money comes from the Biopharmaceutical Investment Program (BIP), part of the provincial government’s Can$1.15 billion Next Generation of Jobs Fund. A total of Can$150 million over five years is available under the BIP, which will cover up to 20% of eligible project costs.

Purdue Pharma Canada plans to break ground for the expansion of its operations in Pickering, Ontario next January. The investment will create 53 jobs in research, development and advanced manufacturing.

Pharmaceutical companies spent around Can$567 million on R&D in Ontario last year. “The biopharmaceutical industry is a sector where Ontario can take on the world and win,” said Minister of Research and Innovation John Wilkinson.